IFN-γ-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 733-743

  Bolinger, Beatrice ^a   Engeler, Daniel ^a   Krebs, Philippe ^a   Miller, Simone ^a   Firner, Sonja ^a   Hoffmann, Matthias ^b   Palmer, Douglas C ^c   Restifo, Nicholas P ^c   Tian, Yinghua ^d   Clavien, Pierre Alain ^d   Ludewig, Burkhard ^a,e  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chronic rejection; CTL; IFN receptor; PD L1; Transplantation; Vascular endothelial cells

Indexed keywords

BETA GALACTOSIDASE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON; RNA; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTERIOSCLEROSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOHISTOLOGY; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; OCCLUSIVE TRANSPLANT VASCULOPATHY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 77749260604     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939706     Document Type: Article

References (59)

1. Libby, P. and Pober, J. S., Chronic rejection. Immunity 2001. 14: 387-397.
2. Schmauss, D. and Weis, M., Cardiac allograft vasculopathy: recent developments. Circulation 2008. 117: 2131-2141.
3. Nankivell, B. J., Borrows, R. J., Fung, C. L., O'Connell, P. J., Allen, R. D. and Chapman, J. R., The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003. 349: 2326-2333.
4. Mitchell, R. N. and Libby, P., Vascular remodeling in transplant vasculopathy. Circ. Res. 2007. 100: 967-978.
5. Tellides, G. and Pober, J. S., Interferon-gamma axis in graft arteriosclerosis. Circ. Res. 2007. 100: 622-632.
6. Valantine, H. A., Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma." Transplantation 2003. 76: 891-899.
7. Rifle, G., Mousson, C. and Herve, P., Endothelial cells in organ transplantation: Friends or foes? Transplantation 2006. 82: S4-S5.
8. Russell, P. S., Chase, C. M., Winn, H. J. and Colvin, R. B., Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am. J. Pathol. 1994. 144: 260-274.
9. Russell, P. S., Chase, C. M., Winn, H. J. and Colvin, R. B., Coronary atherosclerosis in transplanted mouse hearts II Importance of humoral immunity. J. Immunol. 1994. 152: 5135-5141.
10. Russell, P. S., Chase, C. M. and Colvin, R. B., Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997. 64: 1531-1536.
11. Ueland, T., Sikkeland, L. I., Yndestad, A., Eiken, H. G., Holm, T., Guevara, C., Haug, T. et al., Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease. Am. J. Cardiol. 2003. 92: 715-717.
12. Russell, P. S., Chase, C. M., Winn, H. J. and Colvin, R. B., Coronary atherosclerosis in transplanted mouse hearts III Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation 1994. 57: 1367-1371.
13. Nagano, H., Mitchell, R. N., Taylor, M. K., Hasegawa, S., Tilney, N. L. and Libby, P., Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J. Clin. Invest. 1997. 100: 550-557.
14. Gupta, S., Pablo, A. M., Jiang, X. c.,Wang, N., Tall, A. R. and Schindler, C., IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 1997. 99: 2752-2761.
15. -/- mice. Am. J. Pathol. 2000. 157: 1819-1824.
16. Schoenborn, J. R. and Wilson, C. B., Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007. 96:41-101.: 41-101.
17. Tellides, G., Tereb, D. A., Kirkiles-Smith, N. C., Kim, R. W., Wilson, J. H., Schechner, J. S., Lorber, M. I. and Pober, J. S., Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000. 403: 207-211.
18. Badovinac, V. P., Tvinnereim, A. R. and Harty, J. T., Regulation of antigen-specific CD8(+) T cell homeostasis by perforin and interferon-gamma. Science 2000. 290: 1354-1358.
19. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
20. Yang, Y. G., Dey, B. R., Sergio, J. J., Pearson, D. A. and Sykes, M., Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 1998. 102: 2126-2135.
21. Wang, H., Asavaroengchai, W., Yong, Y. B., Wang, M. G., Wang, S., Sykes, M. and Yang, Y. G., Paradoxical effects of IFN-{gamma} in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood. 2009. 113: 3612-3619.
22. Schlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W., Deutsch, U. and Sato, T. N., Uniform vascular-endothelial-cell- specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA 1997. 94: 3058-3063.
23. Bolinger, B., Krebs, P., Tian, Y., Engeler, D., Scandella, E., Miller, S., Palmer, D. C. et al., Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood 2008. 111: 4588-4595.
24. Ochsenbein, A. F., Klenerman, P., Karrer, U., Ludewig, B., Pericin, M., Hengartner, H. and Zinkernagel, R. M., Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. USA 1999. 96: 2233-2238.
25. Ludewig, B., Krebs, P., Junt, T., Metters, H., Ford, N. J., Anderson, R. M. and Bocharov, G., Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction. Eur. J. Immunol. 2004. 34: 2407-2418.
26. Ludewig, B., Odermatt, B., Landmann, S., Hengartner, H. and Zinkernagel, R. M., Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 1998. 188: 1493-1501.
27. Ludewig, B., Junt, T., Hengartner, H. and Zinkernagel, R. M., Dendritic cells in autoimmune diseases. Curr. Opin. Immunol. 2001. 13: 657-662.
28. Hirozane, T., Matsumori, A., Furukawa, Y. and Sasayama, S., Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model. Circulation 1995. 91: 386-392.
29. Paineau, J., Priestley, C., Fabre, J., Chevalier, S., van der,M. P., Schellekens, H., Jacques, Y. and Soulillou, J. P., Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts. J. Heart Lung Transplant. 1991. 10: 424-430.
30. Halloran, P. F., Miller, L. W., Urmson, J., Ramassar, V., Zhu, L. F., Kneteman, N. M., Solez, K. and Afrouzian, M., IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J. Immunol. 2001. 166: 7072-7081.
31. Wherry, E. J. and Ahmed, R., Memory CD8 T-cell differentiation during viral infection. J. Virol. 2004. 78: 5535-5545.
32. Manning, W. C. and Mocarski, E. S., Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 1988. 167: 477-484.
33. del Rio, M. L., Buhler, L., Gibbons, C., Tian, J. and Rodriguez-Barbosa, J. I., PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl. Int. 2008. 21: 1015-1028.
34. Kosuge, H., Suzuki, J., Kakuta, T., Haraguchi, G., Koga, N., Futamatsu, H., Gotoh, R., et al., Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler. Thromb. Vasc. Biol. 2004. 24: 1409-1415.
35. Blackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R. et al., Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2009. 10: 29-37.
36. Sester, U., Presser, D., Dirks, J., Gartner, B. C., Kohler, H. and Sester, M., PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlateswith viremia and reversible functional anergy. Am. J. Transplant. 2008. 8: 1486-1497.
37. Dal Canto, A. J., Virgin, H.W. and Speck, S. H., Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J. Virol. 2000. 74: 11304-11310.
38. Dal Canto, A. J., Swanson, P. E., O'Guin, A. K., Speck, S. H. and Virgin, H.W., IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J. Clin. Invest. 2001. 107: R15-R22.
39. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T. and Honjo, T., PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 2003. 198: 39-50.
40. Kreisel, D., Krupnick, A. S., Gelman, A. E., Engels, F. H., Popma, S. H., Krasinskas, A. M., Balsara, K. R. et al., Non-hematopoietic allograft cells directly activate CD8+T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 2002. 8: 233-239.
41. Valujskikh, A., Lantz, O., Celli, S., Matzinger, P. and Heeger, P. S., Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 2002. 3: 844-851.
42. Bagai, R., Valujskikh, A., Canaday, D. H., Bailey, E., Lalli, P. N., Harding, C. V. and Heeger, P. S., Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway. J. Immunol. 2005. 174: 7711-7715.
43. Limmer, A., Ohl, J., Kurts, C., Ljunggren, H. G., Reiss, Y., Groettrup, M., Momburg, F. et al., Efficient presentation of exogenous antigen by liver endothelial cells to CD8+T cells results in antigen-specific T-cell tolerance. Nat. Med. 2000. 6: 1348-1354.
44. Halloran, P. F., Afrouzian, M., Ramassar, V., Urmson, J., Zhu, L. F., Helms, L. M., Solez, K. and Kneteman, N. M., Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis. Am. J. Pathol. 2001. 158: 215-226.
45. Mele, T. S., Kneteman, N. M., Zhu, L. F., Ramassar, V., Urmson, J., Halloran, B., Churchill, T. A. et al., IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts. Am. J. Transplant. 2003. 3: 942-951.
46. Coley, S. M., Ford, M. L., Hanna, S. C., Wagener, M. E., Kirk, A. D. and Larsen, C. P., IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. J. Immunol. 2009. 182: 225-233.
47. Whitmire, J. K., Tan, J. T. and Whitton, J.L., Interferon-gamma acts directly on CD8+T cells to increase their abundance during virus infection. J. Exp. Med. 2005. 201: 1053-1059.
48. Whitmire, J. K., Benning, N. and Whitton, J. L., Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+T cell responses. J. Immunol. 2005. 175: 5624-5628.
49. Whitmire, J. K., Eam, B., Benning, N. andWhitton, J. L., Direct interferon-gamma signaling dramatically enhances CD4+and CD8+T cell memory. J. Immunol. 2007. 179: 1190-1197.
50. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M. et al., Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006. 203: 883-895.
51. Grabie, N., Gotsman, I., DaCosta, R., Pang, H., Stavrakis, G., Butte, M. J., Keir, M. E. et al., Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+T-cell mediated injury in the heart. Circulation 2007. 116: 2062-2071.
52. Miura, A., Honma, R., Togashi, T., Yanagisawa, Y., Ito, E., Imai, J., Isogai, T. et al., Differential responses of normal human coronary artery endothelial cells against multiple cytokines comparatively assessed by gene expression profiles. FEBS Lett. 2006. 580: 6871-6879.
53. Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
54. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S. et al., Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001. 291: 319-322.
55. Overwijk,W.W., Surman, D. R., Tsung, K. and Restifo, N. P., Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens. Methods 1997. 12: 117-123.
56. Oukka, M., Cohen-Tannoudji, M., Tanaka, Y., Babinet, C. and Kosmatopoulos, K., Medullary thymic epithelial cells induce tolerance to intracellular proteins. J. Immunol. 1996. 156: 968-975.
57. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
58. Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H. and Zinkernagel, R.M., Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 1998. 72: 3812-3818.
59. Corry, R. J.,Winn, H. J. and Russell, P. S., Primarily vascularized allografts of hearts in mice The role of H-2D, H-2 K and non-H-2 antigens in rejection. Transplantation 1973. 16: 343-350.